140 related articles for article (PubMed ID: 7535875)
1. Hypertrophic cardiomyopathy associated with tacrolimus in paediatric transplant patients.
Atkison P; Joubert G; Barron A; Grant D; Paradis K; Seidman E; Wall W; Rosenberg H; Howard J; Williams S
Lancet; 1995 Apr; 345(8954):894-6. PubMed ID: 7535875
[TBL] [Abstract][Full Text] [Related]
2. Tacrolimus related hypertrophic cardiomyopathy in liver transplant recipients.
Dehghani SM; Haghighat M; Imanieh MH; Zahmatkeshan M; Borzooei M; Amoozegar H; Zamirian M; Gholami S; Bahador A; Nikeghbalian S; Salahi H; Malek-Hosseini SA
Arch Iran Med; 2010 Mar; 13(2):116-9. PubMed ID: 20187665
[TBL] [Abstract][Full Text] [Related]
3. Sirolimus in pediatric gastrointestinal transplantation: the use of sirolimus for pediatric transplant patients with tacrolimus-related cardiomyopathy.
Pappas PA; Weppler D; Pinna AD; Rusconi P; Thompson JF; Jaffe JS; Tzakis AG
Pediatr Transplant; 2000 Feb; 4(1):45-9. PubMed ID: 10731058
[TBL] [Abstract][Full Text] [Related]
4. Lack of tacrolimus-induced cardiomyopathy.
Coley KC; Verrico MM; McNamara DM; Park SC; Cressman MD; Branch RA
Ann Pharmacother; 2001 Sep; 35(9):985-9. PubMed ID: 11573873
[TBL] [Abstract][Full Text] [Related]
5. Reversal of tacrolimus-related hypertrophic obstructive cardiomyopathy 5 years after kidney transplant in a 6-year-old recipient.
Jarzembowski TM; John E; Panaro F; Manzelli A; Cabrera A; Greco A; Varga P; Sankary H; Testa G; Benedetti E
Pediatr Transplant; 2005 Feb; 9(1):117-21. PubMed ID: 15667624
[TBL] [Abstract][Full Text] [Related]
6. Tacrolimus-related hypertrophic cardiomyopathy in an adult cardiac transplant patient.
Liu T; Gao Y; Gao YL; Cheng YT; Wang S; Li ZZ; Zhang HB; Meng X; Ma CS; Dong JZ
Chin Med J (Engl); 2012 Apr; 125(7):1352-4. PubMed ID: 22613615
[TBL] [Abstract][Full Text] [Related]
7. Tacrolimus: a cause of hypertrophic cardiomyopathy in pediatric heart transplant recipients?
Scott JS; Boyle GJ; Daubeney PE; Miller SA; Law Y; Pigula F; Griffith BP; Webber SA
Transplant Proc; 1999; 31(1-2):82-3. PubMed ID: 10083017
[No Abstract] [Full Text] [Related]
8. Anasarca and hypertrophic cardiomyopathy in a liver transplant patient on FK506: relieved after a switch to Neoral.
Baruch Y; Weitzman E; Markiewicz W; Eisenman A; Eid A; Enat R
Transplant Proc; 1996 Aug; 28(4):2250-1. PubMed ID: 8769215
[No Abstract] [Full Text] [Related]
9. Reversal of tacrolimus-related hypertrophic cardiomyopathy after conversion to rapamycin in a pediatric liver transplant recipient.
Turska-Kmieć A; Jankowska I; Pawłowska J; Kaliciński P; Kawalec W; Tomyn M; Markiewicz M; Teisseyre J; Czubkowski P; Rekawek J; Socha J
Pediatr Transplant; 2007 May; 11(3):319-23. PubMed ID: 17430490
[TBL] [Abstract][Full Text] [Related]
10. [Hypertrophic cardiomyopathy in preterm newborn with kidney transplanted mother].
Méndez-Abad P; Zafra-Rodríguez P
Arch Argent Pediatr; 2018 Dec; 116(6):e749-e752. PubMed ID: 30457729
[TBL] [Abstract][Full Text] [Related]
11. Arteritis and increased intracellular calcium as a possible mechanism for tacrolimus-related cardiac toxicity in a pediatric transplant recipient.
Atkison PR; Joubert GI; Guiraudon C; Armstrong R; Wall W; Asfar S; Grant D
Transplantation; 1997 Sep; 64(5):773-5. PubMed ID: 9311719
[TBL] [Abstract][Full Text] [Related]
12. Immunosuppressive drugs and hypertrophic cardiomyopathy.
Brand PL; Brus F
Lancet; 1995 Jun; 345(8965):1644. PubMed ID: 7540240
[No Abstract] [Full Text] [Related]
13. Multicenter prospective investigation on cardiovascular adverse effects of tacrolimus in kidney transplantations.
Seino Y; Hori M; Sonoda T
Cardiovasc Drugs Ther; 2003 Mar; 17(2):141-9. PubMed ID: 12975596
[TBL] [Abstract][Full Text] [Related]
14. Tacrolimus and myocardial hypertrophy.
Nakata Y; Yoshibayashi M; Yonemura T; Uemoto S; Inomata Y; Tanaka K; Furusho K
Transplantation; 2000 May; 69(9):1960-2. PubMed ID: 10830241
[TBL] [Abstract][Full Text] [Related]
15. [Tacrolimus and hypertrophic cardiomyopathy].
Romero E; Hevia S; Castellanos D; Simarro C
Med Clin (Barc); 1998 Jun; 110(20):804-5. PubMed ID: 9666425
[No Abstract] [Full Text] [Related]
16. New-onset diabetes mellitus in pediatric thoracic organ recipients receiving tacrolimus-based immunosuppression.
Wagner K; Webber SA; Kurland G; Boyle GJ; Miller SA; Cipriani L; Griffith BP; Fricker FJ
J Heart Lung Transplant; 1997 Mar; 16(3):275-82. PubMed ID: 9087870
[TBL] [Abstract][Full Text] [Related]
17. Immunosuppressive drugs and hypertrophic cardiomyopathy.
Dhawan A; Mack DR; Langnas AN; Shaw BW; Vanderhoof JA
Lancet; 1995 Jun; 345(8965):1644-5. PubMed ID: 7540242
[No Abstract] [Full Text] [Related]
18. Immunosuppressive drugs and hypertrophic cardiomyopathy.
Natazuka T; Ogawa R; Kizaki T; Ueno H; Shiotani H; Koizumi T; Nishimura R; Nakagawa T
Lancet; 1995 Jun; 345(8965):1644. PubMed ID: 7540241
[No Abstract] [Full Text] [Related]
19. Tacrolimus-induced hypertrophic cardiomyopathy in a patient with dermatomyositis.
Noda K; Ukichi T; Furuya K; Yoshida K; Kingetsu I; Tanaka T; Kurosaka D
Rheumatology (Oxford); 2017 Nov; 56(11):2037-2038. PubMed ID: 28977571
[No Abstract] [Full Text] [Related]
20. Immunosuppressive drugs in paediatric liver transplantation.
van Mourik ID; Kelly DA
Paediatr Drugs; 2001; 3(1):43-60. PubMed ID: 11220404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
